H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 74 Citations 22,091 291 World Ranking 12904 National Ranking 6815


What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

His primary areas of investigation include Surgery, Clinical trial, Internal medicine, Radiation therapy and Oncology. While the research belongs to areas of Surgery, Michael A. Vogelbaum spends his time largely on the problem of Adverse effect, intersecting his research to questions surrounding Urology, Local failure and Intermediate risk. Michael A. Vogelbaum has included themes like MEDLINE, Medical imaging, Intensive care medicine, Brain tumor and Magnetic resonance imaging in his Clinical trial study.

Michael A. Vogelbaum specializes in Internal medicine, namely Temozolomide. Michael A. Vogelbaum does research in Radiation therapy, focusing on Radiosurgery specifically. His Oncology study incorporates themes from Tolerability, Multicenter trial, Vocimagene Amiretrorepvec and Antimetabolite.

His most cited work include:

  • Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group (2349 citations)
  • A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma (1528 citations)
  • Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline (368 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Internal medicine, Oncology, Radiosurgery, Surgery and Glioma. His work on Temozolomide, Clinical trial, Hazard ratio and Cancer is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science. His Clinical trial course of study focuses on Intensive care medicine and MEDLINE.

His Oncology research includes themes of Bevacizumab, Chemotherapy, Radiation therapy and Glioblastoma. His work investigates the relationship between Radiosurgery and topics such as Brain metastasis that intersect with problems in Cumulative incidence. His Glioma study integrates concerns from other disciplines, such as Immune system and Pathology.

He most often published in these fields:

  • Internal medicine (37.86%)
  • Oncology (33.74%)
  • Radiosurgery (25.49%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (37.86%)
  • Oncology (33.74%)
  • Glioma (18.45%)

In recent papers he was focusing on the following fields of study:

Michael A. Vogelbaum mostly deals with Internal medicine, Oncology, Glioma, Glioblastoma and Cancer research. His study in Temozolomide, Radiosurgery, Hazard ratio, Bevacizumab and Clinical trial is done as part of Internal medicine. His study in Clinical trial is interdisciplinary in nature, drawing from both Brain tumor, Neurologic Oncology, Response assessment and Intensive care medicine.

His Oncology research includes elements of Cancer, Epidermal growth factor receptor, Brain metastasis, Chemotherapy and Radiation therapy. His studies deal with areas such as Adverse effect and Oligodendroglioma as well as Radiation therapy. His Glioma research is multidisciplinary, incorporating elements of Gastroenterology and Myeloid cells.

Between 2017 and 2021, his most popular works were:

  • Intermediate-risk meningioma: Initial outcomes from NRG Oncology RTOG 0539 (88 citations)
  • Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC. (64 citations)
  • Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis (55 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

Michael A. Vogelbaum focuses on Internal medicine, Oncology, Glioma, Clinical trial and Radiosurgery. His Oncology research is multidisciplinary, incorporating perspectives in Epidermal growth factor receptor, Retrospective cohort study, Meningioma, Resection and Immunotherapy. Michael A. Vogelbaum has researched Glioma in several fields, including Flow cytometry, Mass cytometry and Radiation therapy, Magnetic resonance imaging, Radiology.

His work focuses on many connections between Magnetic resonance imaging and other disciplines, such as Craniotomy, that overlap with his field of interest in Chemotherapy. His study in Clinical trial is interdisciplinary in nature, drawing from both Tumor progression, Neurologic Oncology, Response assessment and Intensive care medicine. Michael A. Vogelbaum has included themes like Lesion, Brain metastasis and Cohort in his Radiosurgery study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

Patrick Y. Wen;David R. Macdonald;David A. Reardon;Timothy F. Cloughesy.
Journal of Clinical Oncology (2010)

2941 Citations

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Mark R. Gilbert;James J. Dignam;Terri S. Armstrong;Terri S. Armstrong;Jeffrey Scott Wefel.
The New England Journal of Medicine (2014)

2085 Citations

Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline

May N. Tsao;Dirk Rades;Andrew Wirth;Simon S. Lo.
Practical radiation oncology (2012)

531 Citations

Response assessment criteria for brain metastases: proposal from the RANO group

Nancy U Lin;Eudocia Q Lee;Hidefumi Aoyama;Igor J Barani.
Lancet Oncology (2015)

425 Citations

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

M. J. van den Bent;J. S. Wefel;D. Schiff;M. J. B. Taphoorn.
Lancet Oncology (2011)

421 Citations

Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells.

Shaik Ohidar Rahaman;Phyllis C Harbor;Olga Chernova;Gene H Barnett.
Oncogene (2002)

417 Citations

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.

Sandeep Kunwar;Susan Chang;Manfred Westphal;Michael Vogelbaum.
Neuro-oncology (2010)

394 Citations

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Nathalie L. Albert;Michael Weller;Bogdana Suchorska;Norbert Galldiks.
Neuro-oncology (2016)

382 Citations

Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review

Leland Rogers;Igor Barani;Marc Chamberlain;Thomas J. Kaley.
Journal of Neurosurgery (2015)

359 Citations

Serum S100β: A Noninvasive Marker of Blood-Brain Barrier Function and Brain Lesions

Andrew A. Kanner;Andrew A. Kanner;Nicola Marchi;Vincent Fazio;Marc R. Mayberg;Marc R. Mayberg.
Cancer (2003)

341 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael A. Vogelbaum

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 197

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 144

Michael Weller

Michael Weller

University of Zurich

Publications: 138

David A. Reardon

David A. Reardon

Harvard University

Publications: 127

Timothy F. Cloughesy

Timothy F. Cloughesy

University of California, Los Angeles

Publications: 114

Arjun Sahgal

Arjun Sahgal

Sunnybrook Health Science Centre

Publications: 111

Mark R. Gilbert

Mark R. Gilbert

The University of Texas MD Anderson Cancer Center

Publications: 87

Martin J. van den Bent

Martin J. van den Bent

Erasmus University Rotterdam

Publications: 75

Susan M. Chang

Susan M. Chang

University of California, San Francisco

Publications: 72

Tracy T. Batchelor

Tracy T. Batchelor

Brigham and Women's Hospital

Publications: 68

John H. Sampson

John H. Sampson

Duke University

Publications: 59

Matthias Preusser

Matthias Preusser

Medical University of Vienna

Publications: 57

Martin Bendszus

Martin Bendszus

University Hospital Heidelberg

Publications: 55

Pieter Wesseling

Pieter Wesseling

University of Amsterdam

Publications: 54

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 51

Jason P. Sheehan

Jason P. Sheehan

University of Virginia

Publications: 50

Something went wrong. Please try again later.